Stay connected. Subscribe to our monthly newsletter.

Artist Talia Greene Presents Exhibit at Esther Klein Gallery Examining COVID-19 Pandemic Vaccine Misinformation

(December 13, 2021- Philadelphia) Following a three-month residency at local biotech company Integral Molecular, visual artist Talia Greene will unveil a solo exhibit, Sense<&-#:>Antisense, which examines misconceptions and distortions around the COVID-19 pandemic. A reference to the sense and antisense strands of DNA and RNA that provide the genetic code for proteins, as well as the everyday meaning of the words, Sense<&-#:>Antisense will open at the University City Science Center’s Esther Klein Gallery on December 16, 2022 and running through February 22 January 20 - March 26, with an Artist Talk taking place at Venture Café Philadelphia on January 20th.

During her residency, Greene worked alongside scientists and researchers to develop the exhibit’s signature piece: Antisense Therapy, a vaccine against COVID-19 misinformation. In this piece, Greene alters the amino acid ‘letter code’ that is used to represent the Spike protein of SARS-CoV-2, to introduce often-heard distortions and falsehoods related to the vaccine and the virus.

In addition to exploring miscommunication between scientists and the public, Greene also delves into communication breakdowns between nations, underscoring how the pandemic has heightened mistrust between countries such as the US and China, further complicating already strained relations. This is displayed through video and prints which meditate on the nature of language, meaning and misunderstanding between countries, as well as between science and society.

The BioArt Residency is made possible through a grant from the Edna Andrade Fund of the Philadelphia Foundation.



About the Artist
Talia Greene is a Philadelphia based artist. Her work focuses on the intersection of history and place in site-specific, wallpaper-based installations. Greene reframes our past to shed light on current topics related to social justice and the environment. In 2018 she received a Percent for Art commission to create an interactive mural at the Philadelphia City Archives. Greene has shown her work in exhibitions across the country and is currently an Adjunct Professor at Drexel University.

About the Science Center
The University City Science Center is Philadelphia’s premier catalyst of entrepreneurial activity, healthcare innovation, and economic growth. Established in 1963, the nonprofit has been recognized by The Brookings Institution as a best-in-class investor, mentor, and economic development partner for young technology companies. Working alongside industry partners and leading research and academic institutions across the globe, the Science Center has supported over 1,000 early-stage companies. Today, the organization advances healthcare innovation from idea to the marketplace through startup support services, allocating capital, gathering the innovation community, and building inclusive STEM pathways for Philadelphia youth and adults. For more information visit sciencecenter.org or follow us at @UCScienceCenter.

About the Esther Klein Gallery
The Esther Klein Gallery (EKG), which opened in 1977, uses the creative arts as a platform to explore relationships between art, science and technology. EKG seeks to positively impact the cultural life of both its immediate neighborhood of West Philadelphia and the broader Philadelphia community. EKG programming is designed to explore the range of art, science and technology exhibitions, and includes gallery talks, panel discussions, and education programs. For more information, visit https://sciencecenter.org/prog...

About Integral Molecular
Integral Molecular is the industry leader in discovering and characterizing therapeutic antibodies against membrane proteins, an important group of drug targets found on the surfaces of cells and viruses. Integral Molecular’s technologies have been integrated into the drug discovery pipelines of over 400 biotech and pharmaceutical companies to help discover new therapies for cancer, diabetes, auto-immune disorders and viral threats such as SARS-CoV-2, Ebola, Zika, and dengue viruses.

Media Contact:

Kristen Fitch Headshot 2024

Kristen Fitch

Senior Director, Marketing